F
Finn Egil Skjeldestad
Researcher at University of Tromsø
Publications - 202
Citations - 9161
Finn Egil Skjeldestad is an academic researcher from University of Tromsø. The author has contributed to research in topics: Population & Pregnancy. The author has an hindex of 34, co-authored 195 publications receiving 8629 citations. Previous affiliations of Finn Egil Skjeldestad include SINTEF & Norwegian Institute of Technology.
Papers
More filters
Journal ArticleDOI
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
Luisa L. Villa,Gonzalo Perez,Susanne K. Kjaer,Jorma Paavonen,Matti Lehtinen,Nubia Muñoz,Kristjan Sigurdsson,Mauricio Hernández-Ávila,Finn Egil Skjeldestad,Steinar Thoresen,Patricia J. Garcia,Slawomir Majewski,Joakim Dillner,Sven Eric Olsson,Hseon Tay Eng,F. Xavier Bosch,Kevin A. Ault,Darron R. Brown,Daron G. Ferris,Laura A. Koutsky,Robert J. Kurman,Evan R. Myers,Eliav Barr,John W. Boslego,Janine T. Bryan,Mark T. Esser,Christine K. Gause,Teresa M. Hesley,Lisa Lupinacci,Heather L. Sings,Frank J. Taddeo,Annemarie R. Thornton +31 more
TL;DR: In young women who had not been previously infected with HPV-16 or HPV-18, those in the vaccine group had a significantly lower occurrence of high-grade cervical intraepithelial neoplasia related to HPV- 16 or HPV -18 than did those inThe placebo group.
Journal ArticleDOI
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Luisa L. Villa,Ronaldo L.R. Costa,Carlos Alberto Petta,Rosires Pereira de Andrade,Kevin A. Ault,Anna R. Giuliano,Cosette M. Wheeler,Laura A. Koutsky,Christian Malm,Matti Lehtinen,Finn Egil Skjeldestad,Sven Eric Olsson,Margareta Steinwall,Darron R. Brown,Robert J. Kurman,Brigitte M. Ronnett,Mark H. Stoler,Alex Ferenczy,Diane M. Harper,Gretchen M. Tamms,Jimmy Yu,Lisa Lupinacci,Radha Railkar,Frank J. Taddeo,Kathrin U. Jansen,Mark T. Esser,Heather L. Sings,Alfred Saah,Eliav Barr +28 more
TL;DR: In this paper, a double-blind placebo-controlled phase II study was done to assess the efficacy of a prophylactic quadrivalent vaccine targeting the human papillomavirus (HPV) types associated with 70% of cervical cancers (types 16 and 18) and with 90% of genital warts (types 6 and 11).
Journal ArticleDOI
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
Øjvind Lidegaard,Lars Hougaard Nielsen,Charlotte Wessel Skovlund,Finn Egil Skjeldestad,Ellen Løkkegaard +4 more
TL;DR: Oral contraceptives with desogestrel, gestodene, or drospirenone were at least at twice the risk of venous thromboembolism compared with users of oral contraceptives with levonorgestrel.
Journal ArticleDOI
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
Luisa L. Villa,Kevin A. Ault,Anna R. Giuliano,Ronaldo L.R. Costa,Carlos Alberto Petta,Rosires Pereira de Andrade,Darron R. Brown,Alex Ferenczy,Diane M. Harper,Laura A. Koutsky,Robert J. Kurman,Matti Lehtinen,Christian Malm,Sven Eric Olsson,Brigitte M. Ronnett,Finn Egil Skjeldestad,Margareta Steinwall,Mark H. Stoler,Cosette M. Wheeler,Frank J. Taddeo,Jimmy Yu,Lisa Lupinacci,Radha Railkar,Rocio D. Marchese,Mark T. Esser,Janine T. Bryan,Kathrin U. Jansen,Heather L. Sings,Gretchen M. Tamms,Alfred J. Saah,Eliav Barr +30 more
TL;DR: Following an initial, similar sized decline, anti-HPV responses plateaued and remained stable through end-of-study (3.0 years), suggesting an anamnestic response.
Journal ArticleDOI
Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study.
TL;DR: Assessment of venous thromboembolism in pregnancy and puerperium in 11 Norwegian counties found different ante- and postnatal risk patterns; whereas cesarean section and preeclampsia were strong postnatalrisk factors.